Stoke Therapeutics
STOK
STOK
67 hedge funds and large institutions have $796M invested in Stoke Therapeutics in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
+3
Holders Change %
+4.69%
% of All Funds
1.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
12
Increased
29
Reduced
15
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$26.2M |
| 2 |
BlackRock
New York
|
+$10.3M |
| 3 |
AG
Artal Group
Luxembourg
|
+$5.73M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$5.16M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.58M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$13.5M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.25M |
| 3 |
Millennium Management
New York
|
-$4.78M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$4.06M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$3.21M |
